project id: TCGA-BRCA; case submitter id: TCGA-LL-A440; source center: 23; state: released; a260 a280 ratio: 2.06; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.55; rna integrity number: 8.6; age at index: 61; days to birth: -22497; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 22497; ajcc pathologic m: MX; ajcc pathologic n: N0 (i-); ajcc pathologic stage: Stage IA; ajcc pathologic t: T1c; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 759.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8520/3; primary diagnosis: Lobular carcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 32; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-LL-A440-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 65.0;